Tag: advogains

During December, 5 care recipients shared having completed their HCV treatment. None of them have undergone SVR 12 test to know whether they have been cured from the HCV infection. The main reason for their inability to get the SVR 12 test done was because of relapsing to drug use. Our data enumerators provided them […]

In late January 2024, a care recipient noted a shortage of direct-acting antiviral (DAA) at his end, with three pills remaining and possibly not getting refill on time for continued treatment. Data enumerator promptly liaised with the Provincial Health Office. It was confirmed that a stock replenishment, including 30 bottles of Elbasvir/Grazoprevir, 168 bottles of […]

May 2023, the community groups in Indonesia organized a protest rally against stock-shortage of direct-acting antivirals used for treatment of hepatitis C. During negotiations at the end of the protest, it was agreed that sofosbuvir/velpatasvir will be added to the national formulary to enable procurements of the same through national programs. Since December 2023, sofosbuvir/velpatasvir […]

During the data collection in during December 2023, we identified a person who have confirmed HCV RNA test result but have not initiated his HCV treatment. The reason he cited was because he was unaware of the services available under the national viral hepatitis control program or any further information. Action Taken: Staff from CoNE […]

Responses from care recipients at Labuang Baji Regional General Hospital (South Sulawesi, Indonesia) indicated that 57% of the care recipients were not aware suggestion box and 40% mentioned there is no suggestion box at the facility. Action taken: Discussions were held with the facility manager and head of the clinic to provide a suggestion box. […]

During data collection, data enumerators, also engages care recipients on other areas of healthcare such as challenges in health insurance, including overdue payment of premiums which may hinder access to treatment since the pre-treatment tests are covered by the insurance. Discussions between data enumerator and hepatitis program managers at the South Sulawesi Provincial Health Office […]

A family member of a person living with hepatitis C approached Peduli Hati Bangsa during July, through social media channels to inquire about availability of medicines to treat hepatitis C in Hasan Sadikin Hospital, Bandung, West Java. Peduli Hati Team followed up with the hospital team and they confirmed that there has been a stock […]

A person undergoing hepatitis C treatment in Fatmawati hospital approached Peduli Hati with concerns that she might not be able to access sofosbuvir/daclatasvir for the 6th month of treatment as there was stock out during March. She was also diagnosed with a cirrhotic liver and had obtained 5 months of medicines from the hospital. Action […]

Peduli Hati Bangsa was involved in the development of the Indonesian CLM Technical Guidelines, adapted from tools that are available now, in the second half of 2023. This is aimed at providing a standard tool for CLM implementors in the country. It is proposed to be published as CLM national guidelines in 2024.

Data enumerator came across a visually challenged person living with HIV at Labuang Baji Regional Hospital, South Sulawesi, Indonesia while collecting data during July. The person was facing consistent difficulty in collecting the HIV medicines every month from the facility. Action taken: An agreement was reached with the manager at the facility that our data […]